CIK 0001894525 · <br>Emerging growth company
Apimeds Pharmaceuticals US, Inc.
Sign in to watch- Ticker
- APUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851099700
- Phone
- 848-201-5010
- Business address
- 100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-11 | Koo Jakap Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2025-11-11 | Yoon Hankil Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2025-11-11 | Weintraub Bennett Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2025-11-11 | Kogan Elona Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2025-11-11 | O'DONNELL CAROL A Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2025-10-15 | Kogan Elona Director | Grant or award · Stock Option (right to buy) | +3,000 | 3,000 | ||
| 2025-10-15 | O'DONNELL CAROL A Director | Grant or award · Stock Option (right to buy) | +3,000 | 3,000 | ||
| 2025-10-15 | Koo Jakap Director | Grant or award · Stock Option (right to buy) | +3,000 | 3,000 | ||
| 2025-10-15 | Yoon Hankil Director | Grant or award · Stock Option (right to buy) | +3,000 | 3,000 | ||
| 2025-10-15 | Weintraub Bennett Director | Grant or award · Stock Option (right to buy) | +3,000 | 3,000 | ||
| 2025-10-15 | Kim Christopher Chairman and CMO | Grant or award · Stock Option (right to buy) | +3,000 | 3,000 | ||
| 2025-10-15 | Emerson Erik C. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +215,000 | 215,000 | ||
| 2025-05-16 | Koo Jakap Director | Grant or award · Stock Option (right to buy) | +5,780 | 5,780 | ||
| 2025-05-16 | Weintraub Bennett Director | Grant or award · Stock Option (right to buy) | +5,780 | 5,780 | ||
| 2025-05-16 | Kogan Elona Director | Grant or award · Stock Option (right to buy) | +5,780 | 5,780 | ||
| 2025-05-16 | Yoon Hankil Director | Grant or award · Stock Option (right to buy) | +5,780 | 5,780 | ||
| 2025-05-16 | O'DONNELL CAROL A Director | Grant or award · Stock Option (right to buy) | +5,780 | 5,780 | ||
| 2025-05-16 | Kim Christopher Chairman and CMO | Grant or award | +250,000 | 277,500 | ||
| 2025-05-16 | Emerson Erik C. Chief Executive Officer | Grant or award | +750,000 | 750,000 | ||
| 2025-05-16 | Emerson Erik C. Chief Executive Officer | Grant or award · Stock option (right to buy) | +347,279 | 347,279 |
Page 1 of 2 · 34 trades